A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease

NCT02127476 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: KHK6640
DRUG: Matching Placebo

Sponsor

Kyowa Kirin Co., Ltd.

Collaborators

[object Object]